Silexion Therapeutics Corp (SLXN)

Biological Products, (No Diagnostic Substances) · Healthcare · $560M

overvalued
Intrinsic Value (Consensus)
$133.09
Current Price
$179.20
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $133
Price: $179

Valuation Model Estimates

Current Price: $179.20
DCF (Discounted Cash Flow)
Not applicable
Graham Number
$12.96
Earnings Power Value
$86.99
Relative Value (P/E)
$179.20
Dividend Discount Model
Not applicable
Consensus Value
$133.09

Model Assumptions

Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%

Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.

Key Financials

EPS (TTM)
$8.96
EPS (Forward)
$9.14
Book Value
$0.83
P/E Ratio
20.0
Forward P/E
19.6
PEG Ratio
ROE
-457.6%
Debt/Equity
Revenue Growth
N/A
Earnings Growth
2.0%
Dividend Yield
N/A
Beta
1.00

Data last updated: 2026-06-12

Source: Yahoo Finance